Therefore, we determined the mRNA expression levels of GIPC1 in addition to MACC1 in a cohort of 59 non-treated human primary CRC specimens of stages I, II, and III, i.e. not distantly metastasized at the time point of analysis. This evidence concerns the gene GIPC1 and colorectal carcinoma.